Ablynx - PDFSEARCH.IO - Document Search Engine

Ablynx
Results: 44

#	Item
21	Nanobodies® creating better medicines Corporate presentation May 2015 Add to Reading List Source URL: www.ablynx.com - Date: 2015-05-22 07:57:36
22	ABLYNX PRESENTS UNIQUE NANOBODY DRUG INHALATION TECHNOLOGY AT THE RESPIRATORY DRUG DELIVERY EUROPE 2015 CONFERENCE GHENT, Belgium, 7 May 2015 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] presented an overview of its Add to Reading List Source URL: hugin.info Language: English - Date: 2015-05-06 06:59:07
23	Microsoft PowerPoint - National day BIOM 2014-v3.pptx Add to Reading List Source URL: www.etro.vub.ac.be Language: English - Date: 2014-12-04 16:22:49 Vrije Universiteit Brussel Ablynx Flemish people Monoclonal antibodies Raymond Hamers Single-domain antibody Heavy-chain antibody Antibody Biopharmaceutical Belgium Flanders Biology
24	Communiqué de Presse MSD Belgique & Luxembourg fière de l’accord de collaboration et de licence avec la société belge de biotechnologie Ablynx Woluwé, le 05 février 2014 Add to Reading List Source URL: www.msd-belgium.be Language: French - Date: 2015-05-29 13:01:37
25	Ackermans & van Haaren - Sipef Ageas Agfa - Gevaert Analist.be Argenta Bekaert Add to Reading List Source URL: www.vfb.be Language: English - Date: 2015-04-22 03:58:29 Vrije Universiteit Brussel FlandersBio Melexis Ablynx Deceuninck Tinc Umicore Ageas Belgium Flanders Science and technology in Belgium
26	INVESTOR FACT SHEET Ablynx is a biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages Add to Reading List Source URL: www.ablynx.com Language: English - Date: 2015-03-23 08:29:54 Boehringer Ingelheim Technology Ablynx Serono Novartis Pharmaceutical industry Pharmaceutical sciences Merck
27	Nanobodies® creating better medicines Corporate presentation April 2015 Add to Reading List Source URL: www.ablynx.com Language: English - Date: 2015-04-02 05:58:33
28	QUARTERLY IR NEWSLETTER Q1 2015 Issue No 16 FIRST WHOLLY-OWNED NANOBODY PRODUCT COULD BE APPROVED FOR SALE IN EUROPE IN Add to Reading List Source URL: www.ablynx.com Language: English - Date: 2015-04-02 06:00:31 Merck & Co. Pharmaceutical industry Ablynx Vrije Universiteit Brussel Single-domain antibody
29	ANNUAL REPORT 2014 INDEX 1. BUSINESS SECTION Add to Reading List Source URL: www.ablynx.com Language: English - Date: 2015-04-07 11:01:36 Monoclonal antibodies Merck Single-domain antibody Serono Pharmaceutical industry Psoriasis Pharmacology Ablynx Vrije Universiteit Brussel Pharmaceutical sciences
30	REGULATED INFORMATION FMR LLC PROVIDES NOTIFICATION OF SHAREHOLDING IN ABLYNX GHENT, Belgium, 15 April 2015 – Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May Add to Reading List Source URL: hugin.info Language: English - Date: 2015-04-14 12:00:52 Ethics Pharmaceutical industry Business law Monoclonal antibodies Forward-looking statement Single-domain antibody Ghent Serono Merck & Co. Vrije Universiteit Brussel Business Ablynx

UPDATE